Eli Lilly to partner with Cipla, Lupin, Sun Pharma to manufacture, distribute Baricitinib in India
US drug-maker Eli Lilly, on May 10, announced that it had issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical manufacturers of... Read More
Cipla launches GLYCOHALE respule
Cipla has annouced the introduction of Glycohale Respules. This helps Cipla to strengthen the Respiratory portfolio. Glycopyrrolate inhalation is indicated for the... Read More
Cipla to acquire four women’s health brands from Wanbury
Cipla has acquired four brands, namely CPink, CDense, Productiv and Folinine, to further strengthen its presence in women’s health portfolio. These brands,... Read More
Cipla – Roche Deal – Cipla will promote and distribute Roche’s tocilizumab and Syndyma in India
Cipla Ltd and Roche Pharma India has entered an agreement under which Cipla will promote and distribute tocilizumab and Syndyma, the 2nd... Read More
Case Study: Cipla Health’s Nicotex Nicotine patches launch in Indian Market
Cipla Health, an arm Cipla with a focus on consumer healthcare products, launched Nicotex Nicotine patches. Nicotex Nicotine patch is a skin/transdermal... Read More
Cipla to acquire pharmaceuticals company Anmarate Pty Ltd
Drugmaker Cipla Ltd’s South African arm has agreed to acquire pharmaceuticals company Anmarate Pty Ltd for ZAR 26.25 million ($1.8 million) in... Read More
Cipla’s Subsidiary forms a JV in Iran
Cipla Holding B.V., a wholly owned subsidiary of the company in Netherlands, Cipla Netherlands, has entered into a joint venture agreement with... Read More
Allergan’s acquisition of Chase Pharmaceuticals – Cipla divests its 16.7% stake in Chase Pharmaceuticals Corp
Allergan plc announced acquisition of Chase Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company focused on the development of improved treatments for neurodegenerative disorders... Read More
Intas Pharma to acquire Teva’s UK, Ireland generics businesses
Intas Pharmaceuticals Ltd agreed to buy Actavis UK Ltd and Actavis Ireland Ltd from Israeli generic drug maker Teva Pharmaceutical Industries Ltd... Read More
Biocon launched Gilead Sciences’ Hepatitis C drug – CIMIVIR-L in India
BIopharmaceutical company Biocon on Thursday said it has launched a generic version of Gilead Sciences’ Hepatitis C drug, Harvoni, in India. The... Read More